GNGBF Getinge AB

USD 19.56 0.00 0
Icon

Getinge AB (GNGBF) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 19.56

0.00 (0.00)%

USD 5.42B

N/A

N/A

N/A

Icon

GNGBF

Getinge AB (USD)
COMMON STOCK | OTC
USD 19.56
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 5.42B

N/A

USD 19.56

Getinge AB (GNGBF) Stock Forecast

N/A

Based on the Getinge AB stock forecast from 0 analysts, the average analyst target price for Getinge AB is not available over the next 12 months. Getinge AB’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Getinge AB is Bullish , which is based on 9 positive signals and 3 negative signals. At the last closing, Getinge AB’s stock price was USD 19.56. Getinge AB’s stock price has changed by +0.00% over the past week, -3.41% over the past month and -14.96% over the last year.

No recent analyst target price found for Getinge AB
No recent average analyst rating found for Getinge AB

Company Overview Getinge AB

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing sys...Read More

https://www.getinge.com

Lindholmspiren 7A, Gothenburg, Sweden, 417 56

11,739

December

USD

USA

Adjusted Closing Price for Getinge AB (GNGBF)

Loading...

Unadjusted Closing Price for Getinge AB (GNGBF)

Loading...

Share Trading Volume for Getinge AB Shares

Loading...

Compare Performance of Getinge AB Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for GNGBF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Getinge AB (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SMMNY
Siemens Healthineers AG ADR +0.07 (+0.23%) USD67.12B 40.46 16.99

ETFs Containing GNGBF

Symbol Name GNGBF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Getinge AB (GNGBF) Stock

Stock Target Advisor's fundamental analysis for Getinge AB's stock is Bullish .

GNGBF stock's dividend yield is 2.16%. Our analysis grades GNGBF stock's dividend yield at C+. This means that GNGBF stock's dividend yield is above 79% of the stocks in the Medical Devices sector in the OTC exchange. Based on this GNGBF may be a average dividend stock for its sector.

Unfortunately we do not have enough data on GNGBF's stock to indicate what its average analyst target is.

GNGBF stock's Price/Earning ratio is 24.45. Our analysis grades GNGBF stock's Price / Earning ratio at F. This means that GNGBF stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Medical Devices sector in the OTC exchange. Based on this GNGBF may be fairly valued for its sector

The last closing price of GNGBF's stock was USD 19.56.

The most recent market capitalization for GNGBF is USD 5.42B.

Unfortunately we do not have enough analyst data on GNGBF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Getinge AB's stock.

As per our most recent records Getinge AB has 11,739 Employees.

Getinge AB's registered address is Lindholmspiren 7A, Gothenburg, Sweden, 417 56. You can get more information about it from Getinge AB's website at https://www.getinge.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...